161 related articles for article (PubMed ID: 33739293)
21. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
22. Tumour-stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJ; Backes Y; Elias SG; Seerden TC; Schwartz MP; Spanier BW; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JM; Groen JN; Ter Borg F; Wolfhagen FH; Seldenrijk CA; Raicu MG; Milne AN; van Lent AU; Brosens LA; Offerhaus GJA; Siersema PD; Tollenaar RA; Hardwick JC; Hawinkels LJ; Moons LM; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2020 Nov; 9(4):2050640620975324. PubMed ID: 33210982
[TBL] [Abstract][Full Text] [Related]
23. Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer.
Geessink OGF; Baidoshvili A; Klaase JM; Ehteshami Bejnordi B; Litjens GJS; van Pelt GW; Mesker WE; Nagtegaal ID; Ciompi F; van der Laak JAWM
Cell Oncol (Dordr); 2019 Jun; 42(3):331-341. PubMed ID: 30825182
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer.
Jasani B; Bänfer G; Fish R; Waelput W; Sucaet Y; Barker C; Whiteley JL; Walker J; Hovelinck R; Diezko R
Diagn Pathol; 2020 Apr; 15(1):37. PubMed ID: 32303234
[TBL] [Abstract][Full Text] [Related]
25. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
26. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
Chen Y; Zhang L; Liu W; Liu X
Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
[TBL] [Abstract][Full Text] [Related]
28. Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJC; Backes Y; Elias SG; Seerden TCJ; Schwartz MP; Spanier BWM; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JMJ; Groen JN; Borg FT; Wolfhagen FHJ; Seldenrijk CA; Raicu MG; Milne AN; van Lent AUG; Brosens LAA; Johan A Offerhaus G; Siersema PD; Tollenaar RAEM; Hardwick JCH; Hawinkels LJAC; Moons LMG; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2021 Feb; ():. PubMed ID: 33566452
[TBL] [Abstract][Full Text] [Related]
29. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
[TBL] [Abstract][Full Text] [Related]
30. Investigating the role of core needle biopsy in evaluating tumor-stroma ratio (TSR) of invasive breast cancer: a retrospective study.
Le MK; Odate T; Kawai M; Oishi N; Kondo T
Breast Cancer Res Treat; 2023 Jan; 197(1):113-121. PubMed ID: 36335529
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric MRI-based radiomics signature for preoperative estimation of tumor-stroma ratio in rectal cancer.
Cai C; Hu T; Gong J; Huang D; Liu F; Fu C; Tong T
Eur Radiol; 2021 May; 31(5):3326-3335. PubMed ID: 33180166
[TBL] [Abstract][Full Text] [Related]
35. Digital image analysis provides robust tissue microenvironment-based prognosticators in patients with stage I-IV colorectal cancer.
Jakab A; Patai ÁV; Micsik T
Hum Pathol; 2022 Oct; 128():141-151. PubMed ID: 35820451
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the Tumor-Stroma Ratio and Tumor-Infiltrating Lymphocytes in Colorectal Cancer: Inter-Observer Agreement Evaluation.
Kazemi A; Gharib M; Mohamadian Roshan N; Taraz Jamshidi S; Stögbauer F; Eslami S; Schüffler PJ
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510083
[TBL] [Abstract][Full Text] [Related]
37. Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression.
Nastały P; Smentoch J; Popęda M; Martini E; Maiuri P; Żaczek AJ; Sowa M; Matuszewski M; Szade J; Kalinowski L; Niemira M; Brandt B; Eltze E; Semjonow A; Bednarz-Knoll N
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834440
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE
Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133
[TBL] [Abstract][Full Text] [Related]
39. Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer.
Zunder SM; Perez-Lopez R; de Kok BM; Raciti MV; van Pelt GW; Dienstmann R; Garcia-Ruiz A; Meijer CA; Gelderblom H; Tollenaar RA; Nuciforo P; Wasser MN; Mesker WE
Eur J Radiol; 2020 Dec; 133():109345. PubMed ID: 33120239
[TBL] [Abstract][Full Text] [Related]
40. Utility of Indigenously Developed Square Grid Method for Evaluation of Tumor-Stroma Ratio and Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma: A Pilot Study.
Kumarguru BN; Ramaswamy AS; Arathi CA; Swathi D
Iran J Pathol; 2023; 18(3):335-346. PubMed ID: 37942205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
